Page last updated: 2024-11-04

2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one: from maize extracts; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

DIMBOA : A lactol that is DIBOA in which the hydrogen at position 7 is replaced by a methoxy group. It has been isolated from the maize plants. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2358
CHEMBL ID2269101
CHEBI ID18048
SCHEMBL ID912624
MeSH IDM0144700

Synonyms (36)

Synonym
CHEBI:18048 ,
brn 1078658
2,4-dihydroxy-7-methoxy-1,4-benzoxazinone
2h-1,4-benzoxazin-3(4h)-one, 2,4-dihydroxy-7-methoxy-
2,4-dihydroxy-7-methoxy-2h,1,4-benzoxazin-3(4h)one
dimboa
15893-52-4
2,4-dihydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one
2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one
C04720
inchi=1/c9h9no5/c1-14-5-2-3-6-7(4-5)15-9(12)8(11)10(6)13/h2-4,9,12-13h,1h
(2r)-2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one
2,4-dihydroxy-7-methoxy-4h-[1,4]benzoxazin-3-one
ti783ru0dr ,
unii-ti783ru0dr
CHEMBL2269101
SCHEMBL912624
AKOS024385514
(+/-)-dimboa
(+/-)-2,4-dihydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one
2,4-dihydroxy-7-methoxy-3,4-dihydro-2h-1,4-benzoxazin-3-one
GDNZNIJPBQATCZ-UHFFFAOYSA-N
DTXSID90936021
EX-A4012
Q1748422
dimboa pound>>2,4-dihydroxy-7-methoxy-1,4-benzoxazinone;2,4-dihydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one
BCP31438
CS-0128391
HY-N7432
D94538
2,4-dihydroxy-7-methoxy-1,4-benzoxazine-3-one (dimboa) 100 microg/ml in acetonitrile
2,4-dihydroxy-7-methoxy-2h-benzo[b][1,4]oxazin-3(4h)-one ,
2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one
AS-77472
2,4-dihydroxy-7-methoxy-2h,1,4-benzoxazin-3(4h)-one
(+/-)-dimboa;

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Effectively controlling target organisms while reducing the adverse effects of pesticides on non-target organisms is a crucial scientific inquiry and challenge in pesticide ecotoxicology research."( Phytotoxicity alleviation of imazethapyr to non-target plant wheat: active regulation between auxin and DIMBOA.
Chen, H; Huang, J; Li, J; Shen, C; Wen, Y, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" by root allelopathy in a dose-response bioassay."( Differential exudation of two benzoxazinoids--one of the determining factors for seedling allelopathy of Triticeae species.
Belz, RG; Hurle, K, 2005
)
0.33
" ED50 doses of the pure compounds were estimated in dose-response experiments in Petri dishes, and these turned out to be much higher than the predicted maximum concentrations of DIMBOA, MBOA, and BOA in the soil water following incorporation."( Herbicidal effects of soil-incorporated wheat.
Kudsk, P; Mathiassen, SK; Mogensen, BB, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
allelochemicalA class of secondary metabolites developed by many plants to influence the behaviour, growth or survival of herbivores, and thus acting as a defence against herbivory.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
cyclic hydroxamic acidA lactam having a hydroxy substituent on the amide nitrogen.
lactolCyclic hemiacetals formed by intramolecular addition of a hydroxy group to an aldehydic or ketonic carbonyl group. They are thus 1-oxacycloalkan-2-ols or unsaturated analogues.
benzoxazine
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
DIMBOA-glucoside activation15

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1585947Antifungal activity against Candida albicans after 24 hrs by spectrophotometric method2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
QSAR of 1,4-benzoxazin-3-one antimicrobials and their drug design perspectives.
AID1103171Antifeedant activity against third-instar larvae of Rhopalosiphum padi assessed as repellency index after 24 hr by feeding choice assay2004Journal of agricultural and food chemistry, May-05, Volume: 52, Issue:9
Chemical basis for the antifeedant activity of natural hydroxamic acids and related compounds.
AID1585944Antifungal activity against Candida albicans after 24 hrs by disk diffusion method2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
QSAR of 1,4-benzoxazin-3-one antimicrobials and their drug design perspectives.
AID1585946Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by disk diffusion method2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
QSAR of 1,4-benzoxazin-3-one antimicrobials and their drug design perspectives.
AID1585945Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by disk diffusion method2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
QSAR of 1,4-benzoxazin-3-one antimicrobials and their drug design perspectives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (93)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (2.15)18.7374
1990's4 (4.30)18.2507
2000's47 (50.54)29.6817
2010's31 (33.33)24.3611
2020's9 (9.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.74 (24.57)
Research Supply Index4.58 (2.92)
Research Growth Index5.33 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (3.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other94 (96.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]